The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(2-(6-methoxyquinolin-4-yl)ethyl)-trans-1,3-dioxan-5-yl)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carboxamide ID: ALA4755744
PubChem CID: 162655867
Max Phase: Preclinical
Molecular Formula: C25H25N3O6
Molecular Weight: 463.49
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2nccc(CC[C@H]3OC[C@H](NC(=O)c4ccc5c(c4)NC(=O)CO5)CO3)c2c1
Standard InChI: InChI=1S/C25H25N3O6/c1-31-18-4-5-20-19(11-18)15(8-9-26-20)3-7-24-33-12-17(13-34-24)27-25(30)16-2-6-22-21(10-16)28-23(29)14-32-22/h2,4-6,8-11,17,24H,3,7,12-14H2,1H3,(H,27,30)(H,28,29)/t17-,24-
Standard InChI Key: ZFMCWMJGTDHLKI-WVQHILGCSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
5.0143 -28.5672 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7281 -28.1537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7253 -27.3269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0125 -26.9216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3021 -28.1541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3044 -27.3322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5944 -26.9232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8857 -27.3307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8873 -28.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5939 -28.5653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1738 -26.9223 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0090 -26.1003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7191 -25.6845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4327 -26.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4315 -26.9144 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1410 -27.3199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8535 -26.9118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8520 -26.0895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1380 -25.6754 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5614 -27.3200 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2731 -26.9111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9851 -27.3193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2727 -26.0897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1716 -26.1051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9835 -28.1400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6947 -28.5481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6883 -26.9061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4001 -27.3106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4034 -28.1353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1153 -28.5426 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8285 -28.1297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8253 -27.3049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1088 -26.8931 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5318 -26.8942 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 5 2 0
8 11 1 0
4 12 1 0
12 13 1 0
14 13 1 1
14 15 1 0
14 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
17 20 1 6
20 21 1 0
21 22 1 0
21 23 2 0
11 24 1 0
22 25 2 0
25 26 1 0
26 29 2 0
28 27 2 0
27 22 1 0
28 29 1 0
28 33 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
32 34 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 463.49Molecular Weight (Monoisotopic): 463.1743AlogP: 2.68#Rotatable Bonds: 6Polar Surface Area: 108.01Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.47CX Basic pKa: 5.22CX LogP: 2.18CX LogD: 2.18Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.58Np Likeness Score: -0.65
References 1. Lu Y,Papa JL,Nolan S,English A,Seffernick JT,Shkolnikov N,Powell J,Lindert S,Wozniak DJ,Yalowich J,Mitton-Fry MJ. (2020) Dioxane-Linked Amide Derivatives as Novel Bacterial Topoisomerase Inhibitors against Gram-Positive Staphylococcus aureus., 11 (12): [PMID:33335666 ] [10.1021/acsmedchemlett.0c00428 ]